doi: 10.1016/s1470-2045(12)70008-6.
NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are resistant or intolerant to imatinib
- PMID: 22403810
- DOI: 10.1016/s1470-2045(12)70008-6
Item in Clipboard
NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are resistant or intolerant to imatinib
Lancet Oncol.
2012 Feb.
No abstract available
Similar articles
-
Dasatinib for the treatment of Philadelphia chromosome-positive chronic myelogenous leukaemia after imatinib failure.Expert Opin Pharmacother. 2007 Dec;8(18):3257-64. doi: 10.1517/14656566.8.18.3257. Expert Opin Pharmacother. 2007. PMID: 18035968 Review.
-
Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis.Blood. 2007 Apr 15;109(8):3207-13. doi: 10.1182/blood-2006-09-046888. Epub 2006 Dec 21. Blood. 2007. PMID: 17185463 Clinical Trial.
-
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib.J Hematol Oncol. 2010 Nov 26;3:47. doi: 10.1186/1756-8722-3-47. J Hematol Oncol. 2010. PMID: 21108851 Free PMC article. Review.
-
Nilotinib and dasatinib first-line: are we ready for imatinib replacement?Leuk Res. 2011 Sep;35(9):1153-5. doi: 10.1016/j.leukres.2011.02.004. Epub 2011 Feb 25. Leuk Res. 2011. PMID: 21353701 No abstract available.
-
Beyond dose escalation: clinical options for relapse or resistance in chronic myelogenous leukemia.J Natl Compr Canc Netw. 2008 Mar;6 Suppl 2:S22-S30. J Natl Compr Canc Netw. 2008. PMID: 18397678 Review.
Cited by
-
Use patterns of first-line inhibitors of tyrosine kinase and time to change to second-line therapy in chronic myeloid leukemia.Int J Clin Pharm. 2017 Aug;39(4):851-859. doi: 10.1007/s11096-017-0484-9. Epub 2017 May 15. Int J Clin Pharm. 2017. PMID: 28508322
-
Potential therapies for anaplastic lymphoma kinase-driven tumors in children: progress to date.Paediatr Drugs. 2013 Jun;15(3):163-9. doi: 10.1007/s40272-013-0027-3. Paediatr Drugs. 2013. PMID: 23696342 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical